| McKesson To Spin-Off Its Medical-Surgical Solutions Business |
Deal OverviewOn May 8, 2025, McKesson Corporation (NYSE: MCK, $682.28, Market Capitalization: $85.4 billion), a diversified healthcare services company, announced its intention to separate its Medical-Surgical Solutions segment into an independent company (NewCo) (for more information, visit spinoffresearch.com). McKesson is committed to exploring all opportunities to execute a separation in a manner that maximizes shareholder value and anticipates providing more information as appropriate on the form and timing as the process progresses. |
forbes.com |
2025-05-15 18:05:03 |
Czytaj oryginał (ang.) |
| 3 Reasons Growth Investors Will Love McKesson (MCK) |
McKesson (MCK) possesses solid growth attributes, which could help it handily outperform the market. |
zacks.com |
2025-05-14 17:45:39 |
Czytaj oryginał (ang.) |
| McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know |
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. |
zacks.com |
2025-05-14 14:06:22 |
Czytaj oryginał (ang.) |
| McKesson Corporation (MCK) CFO Britt Vitalone Hosts BofA Securities 2025 Healthcare Conference (Transcript) |
McKesson Corporation (NYSE:MCK ) BofA Securities 2025 Healthcare Conference May 13, 2025 11:00 AM ET Company Participants Britt Vitalone - Chief Financial Officer Conference Call Participants Allen Lutz - Bank of America Allen Lutz Welcome to day one of the BofA Healthcare Conference here in Las Vegas. We are very excited to welcome McKesson here. |
seekingalpha.com |
2025-05-13 19:37:51 |
Czytaj oryginał (ang.) |
| Why McKesson (MCK) is a Top Momentum Stock for the Long-Term |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-05-12 14:55:49 |
Czytaj oryginał (ang.) |
| Why McKesson Stock Bumped Modestly Higher Today |
Storied healthcare supplies company McKesson (MCK 0.34%) was a slight outperformer on the stock exchange Friday, as investors considered its results for its fourth quarter of fiscal 2025. They liked, if not loved, what they saw, sending the shares to a 0.5% gain on that day. |
fool.com |
2025-05-09 21:03:33 |
Czytaj oryginał (ang.) |
| McKesson: Spinoff Of Medical-Surgical Solutions Is A Positive, Strong Buy |
I reiterate a Strong Buy rating on McKesson Corporation with a fair value of $828 per share, driven by robust growth in the oncology and biopharma sectors. McKesson posted 19% revenue growth and 63.8% adj. EPS growth, largely driven by strong demand for GLP-1 products, which now represent 12% of total revenue. The company's global supply chain flexibility and non-discretionary drug pricing render it largely immune to tariff uncertainties, ensuring stable future growth. |
seekingalpha.com |
2025-05-09 16:49:28 |
Czytaj oryginał (ang.) |
| MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off |
McKesson's fourth-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales. |
zacks.com |
2025-05-09 14:30:52 |
Czytaj oryginał (ang.) |
| McKesson Corporation (MCK) Q4 2025 Earnings Call Transcript |
McKesson Corporation (NYSE:MCK ) Q4 2025 Earnings Conference Call May 8, 2025 4:30 PM ET Company Participants Brian Tyler - Chief Executive Officer Britt Vitalone - Chief Financial Officer Jeni Dominguez - VP of Investor Relations Conference Call Participants Kevin Caliendo - UBS Lisa Gill - JP Morgan Allen Lutz - Bank of America Eric Percher - Nephron Research Stephen Baxter - Wells Fargo Daniel Grosslight - Citi Eric Coldwell - Baird Elizabeth Anderson - Evercore ISI Charles Rhyee - TD Cowen Operator Presentation Operator Welcome to McKesson's Fourth Quarter Fiscal 2025 Earnings Conference Call. Please be advised that today's conference is being recorded. |
seekingalpha.com |
2025-05-09 00:08:14 |
Czytaj oryginał (ang.) |
| Here's What Key Metrics Tell Us About McKesson (MCK) Q4 Earnings |
While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-05-08 23:05:34 |
Czytaj oryginał (ang.) |
| McKesson (MCK) Tops Q4 Earnings Estimates |
McKesson (MCK) came out with quarterly earnings of $10.12 per share, beating the Zacks Consensus Estimate of $9.81 per share. This compares to earnings of $6.18 per share a year ago. |
zacks.com |
2025-05-08 22:35:35 |
Czytaj oryginał (ang.) |
| McKesson to spin off surgical supplies unit, forecasts strong annual profit |
McKesson forecast fiscal 2026 profit largely above estimates on Thursday and said it is planning to spin off its medical-surgical solutions unit into an independent company to focus on its core drug distribution business. |
reuters.com |
2025-05-08 21:45:35 |
Czytaj oryginał (ang.) |
| McKesson to Spin Off Medical-Surgical Company |
The pharmaceutical distributor said the new company would be a differentiated medical surgical supply and solutions business. |
wsj.com |
2025-05-08 21:40:00 |
Czytaj oryginał (ang.) |
| McKesson Reports Fiscal 2025 Fourth Quarter and Full Year Results and Provides Fiscal 2026 Guidance; Announces Intent to Separate Medical-Surgical Solutions |
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Thursday, May 8th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live and arc. |
businesswire.com |
2025-05-08 20:10:00 |
Czytaj oryginał (ang.) |
| How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings |
McKesson Corporation MCK will release its fourth-quarter financial results after the closing bell on Thursday. |
benzinga.com |
2025-05-08 12:48:27 |
Czytaj oryginał (ang.) |
| Brokers Suggest Investing in McKesson (MCK): Read This Before Placing a Bet |
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? |
zacks.com |
2025-05-06 14:36:27 |
Czytaj oryginał (ang.) |
| MCK Stock Up 24% YTD: Should You Buy, Hold or Sell Before Q4 Earnings? |
McKesson's fourth-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume. |
zacks.com |
2025-05-06 12:15:45 |
Czytaj oryginał (ang.) |
| McKesson (MCK) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures |
Besides Wall Street's top -and-bottom-line estimates for McKesson (MCK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025. |
zacks.com |
2025-05-05 14:20:56 |
Czytaj oryginał (ang.) |
| McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release |
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-05-01 15:08:38 |
Czytaj oryginał (ang.) |
| McKesson (MCK) Laps the Stock Market: Here's Why |
McKesson (MCK) closed at $712.79 in the latest trading session, marking a +0.78% move from the prior day. |
zacks.com |
2025-04-30 22:55:41 |
Czytaj oryginał (ang.) |
| Is Most-Watched Stock McKesson Corporation (MCK) Worth Betting on Now? |
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. |
zacks.com |
2025-02-26 12:00:32 |
Czytaj oryginał (ang.) |
| McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know |
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. |
zacks.com |
2025-02-11 12:05:36 |
Czytaj oryginał (ang.) |
| Should You Buy, Hold or Sell MCK Stock Following Robust Q3 Earnings? |
McKesson MCK delivered an 18% increase in revenues ($95.3 billion) and a 16% rise in adjusted operating profit during the third quarter of fiscal 2025 despite ongoing macroeconomic challenges. The company also raised its full-year guidance. |
zacks.com |
2025-02-11 10:41:09 |
Czytaj oryginał (ang.) |
| These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar |
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. |
zacks.com |
2025-02-07 11:50:21 |
Czytaj oryginał (ang.) |
| MCK Stock Down on Q3 Earnings & Sales Miss, Gross Margin Contracts |
McKesson's third-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales. |
zacks.com |
2025-02-06 10:06:12 |
Czytaj oryginał (ang.) |
| McKesson Corporation (MCK) Q3 2025 Earnings Call Transcript |
McKesson Corporation. (NYSE:MCK ) Q3 2025 Earnings Conference Call February 5, 2025 4:30 PM ET Company Participants Rachel Rodriguez - VP of Investor Relations Brian Tyler - Chief Executive Officer Britt Vitalone - Executive Vice President and Chief Financial Officer Conference Call Participants Eric Percher - Nephron Research Kevin Caliendo - UBS Allen Lutz - Bank of America Brian Tanquilut - Jefferies Lisa Gill - JPMorgan Stephen Baxter - Wells Fargo Erin Wright - Morgan Stanley George Hill - Deutsche Bank Daniel Grosslight - Citi Operator Welcome to McKesson's Third Quarter Fiscal 2025 Earnings Conference Call. |
seekingalpha.com |
2025-02-05 22:20:18 |
Czytaj oryginał (ang.) |
| Here's What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings |
While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
zacks.com |
2025-02-05 21:01:20 |
Czytaj oryginał (ang.) |
| McKesson (MCK) Q3 Earnings and Revenues Miss Estimates |
McKesson (MCK) came out with quarterly earnings of $8.03 per share, missing the Zacks Consensus Estimate of $8.04 per share. This compares to earnings of $7.74 per share a year ago. |
zacks.com |
2025-02-05 20:25:19 |
Czytaj oryginał (ang.) |
| McKesson misses third-quarter revenue estimates |
Drug distributor McKesson missed estimates for third-quarter revenue on Wednesday, hurt by less-than-expected sales in its U.S. pharmaceutical segment, which includes branded and specialty drugs. |
reuters.com |
2025-02-05 20:05:22 |
Czytaj oryginał (ang.) |
| McKesson Exceeds EPS, Q3 Profit Surges |
Healthcare distribution and services specialist McKesson (MCK 0.59%) reported mixed financial results for fiscal 2025's third quarter on Wednesday, Feb. 5. McKesson beat earnings expectations with an adjusted EPS of $8.03, coming in just ahead of the projected $8.01. |
fool.com |
2025-02-05 19:33:20 |
Czytaj oryginał (ang.) |
| McKesson Corporation Reports Fiscal 2025 Third Quarter Results and Raises Full Year Adjusted EPS Guidance |
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, February 5th at 4:30 PM ET to review its financial results. The audio webcast of the conference call will be available live an. |
businesswire.com |
2025-02-05 18:10:00 |
Czytaj oryginał (ang.) |
| McKesson Stock May Rise With PRISM Vision Holdings Acquisition |
MCK is set to acquire a controlling stake in PRISM Vision Holdings, aiming to expand its specialty care capabilities and strengthen its leadership in eye health solutions across the United States. |
zacks.com |
2025-02-05 15:00:49 |
Czytaj oryginał (ang.) |
| MCK Stock Before Q3 Earnings: A Smart Buy or Risky Investment? |
McKesson's third-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume. |
zacks.com |
2025-02-04 10:45:35 |
Czytaj oryginał (ang.) |
| McKesson (MCK) Declines More Than Market: Some Information for Investors |
In the closing of the recent trading day, McKesson (MCK) stood at $594.75, denoting a -1.63% change from the preceding trading day. |
zacks.com |
2025-01-31 20:56:18 |
Czytaj oryginał (ang.) |
| Gear Up for McKesson (MCK) Q3 Earnings: Wall Street Estimates for Key Metrics |
Evaluate the expected performance of McKesson (MCK) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. |
zacks.com |
2025-01-31 12:21:34 |
Czytaj oryginał (ang.) |
| McKesson Corporation Declares Quarterly Dividend |
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on April 1, 2025, to stockholders of record on March 3, 2025. About McKesson Corporation McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers. |
businesswire.com |
2025-01-30 10:00:00 |
Czytaj oryginał (ang.) |
| McKesson (MCK) Earnings Expected to Grow: What to Know Ahead of Next Week's Release |
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. |
zacks.com |
2025-01-29 13:06:39 |
Czytaj oryginał (ang.) |
| McKesson (MCK) Stock Drops Despite Market Gains: Important Facts to Note |
McKesson (MCK) closed at $602.95 in the latest trading session, marking a -0.24% move from the prior day. |
zacks.com |
2025-01-28 21:06:27 |
Czytaj oryginał (ang.) |
| McKesson's Practice Insights Selected as a 2025 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services |
IRVING, Texas--(BUSINESS WIRE)--For the ninth year, CMS has named McKesson a Qualified Clinical Data Registry approved to participate in the Merit-based Incentive Payment System. |
businesswire.com |
2025-01-23 10:00:00 |
Czytaj oryginał (ang.) |
| McKesson (MCK) Stock Declines While Market Improves: Some Information for Investors |
McKesson (MCK) closed at $586.08 in the latest trading session, marking a -1.1% move from the prior day. |
zacks.com |
2025-01-21 21:05:34 |
Czytaj oryginał (ang.) |
| McKesson Stock Declines Post Divestiture of Canada-Based Businesses |
MCK aims to focus on capital deployment and prioritize investments to strengthen its strategic oncology and biopharma growth platforms. |
zacks.com |
2025-01-02 14:20:40 |
Czytaj oryginał (ang.) |
| McKesson Corporation Completes Divestiture of Canada-Based Rexall and Well.ca Businesses |
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) reported today that on December 30, 2024 it has closed the transaction announced in September 2024 to sell its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a Canadian private equity firm. This transaction enables the Company to focus capital deployment and prioritize investments expanding its strategic oncology and biopharma growth platforms. Additional details related to the divestiture can be found o. |
businesswire.com |
2024-12-31 10:00:00 |
Czytaj oryginał (ang.) |
| Why McKesson (MCK) is a Top Value Stock for the Long-Term |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2024-12-30 12:46:41 |
Czytaj oryginał (ang.) |
| 5 Beaten-Down MedTech Stocks Set to Rebound in 2025 |
Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape. |
zacks.com |
2024-12-30 11:25:28 |
Czytaj oryginał (ang.) |
| McKesson Corporation Announces Third Quarter Fiscal 2025 Earnings Release Date and Participation in January Conference |
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2025 financial results after market close on Wednesday, February 5, 2025. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. Chief Executive Officer Brian Tyler and Chief Financial Officer Britt Vitalone will be participating in the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025. |
businesswire.com |
2024-12-30 10:00:00 |
Czytaj oryginał (ang.) |
| Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know |
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. |
zacks.com |
2024-12-25 12:01:20 |
Czytaj oryginał (ang.) |
| Are Investors Undervaluing McKesson (MCK) Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-12-23 12:46:32 |
Czytaj oryginał (ang.) |
| 4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2025 |
Investing in large-cap MedTech stocks like MCK, PEN, CAH and PEN can be profitable for investors in 2025. |
zacks.com |
2024-12-20 12:26:08 |
Czytaj oryginał (ang.) |
| Best Growth Stocks to Buy for December 20th |
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 20th: |
zacks.com |
2024-12-20 12:00:41 |
Czytaj oryginał (ang.) |
| Buy 5 Value Stocks Amid Strong Upside Potential in the Short Term |
Five value stocks have strong revenues and earnings potential in 2025. These are: FAF, MCK, LDOS, SKYW, GAP. |
zacks.com |
2024-12-20 11:31:12 |
Czytaj oryginał (ang.) |
| 3 Top Ranked Stocks to Buy for 2025 (GPOR, MCK, MRVL) |
Following Wednesday's FOMC meeting and press conference from Jerome Powell, it seems 2025 may be shaping up to be a bit more uncertain than investors were expecting. Powell expressed his concern about rising inflation and signaled the central bank was going to be more hawkish moving forward. |
zacks.com |
2024-12-19 16:25:21 |
Czytaj oryginał (ang.) |
| Best Growth Stocks to Buy for December 19th |
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 19th: |
zacks.com |
2024-12-19 12:20:32 |
Czytaj oryginał (ang.) |
| Best Growth Stocks to Buy for December 18th |
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 18th: |
zacks.com |
2024-12-18 11:35:27 |
Czytaj oryginał (ang.) |
| Best Value Stocks to Buy for December 18th |
LTM, BBAR and MCK made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 18, 2024. |
zacks.com |
2024-12-18 11:16:21 |
Czytaj oryginał (ang.) |
| Reasons to Add McKesson Stock to Your Portfolio Right Now |
MCK's strategic collaborations and strength in Biologics raise optimism about the stock. |
zacks.com |
2024-12-18 10:36:12 |
Czytaj oryginał (ang.) |
| Prescription for Profits: 3 Must-Buy Healthcare Stocks Before 2025 |
The healthcare sector is undergoing significant changes, with technology, innovation and a patient-centric approach as the cornerstones of its growth. |
zacks.com |
2024-12-16 18:01:09 |
Czytaj oryginał (ang.) |
| Best Growth Stocks to Buy for December 16th |
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today December 16th: |
zacks.com |
2024-12-16 12:10:21 |
Czytaj oryginał (ang.) |
| Best Value Stocks to Buy for December 16th |
ZIM, MCK and DFH made it to the Zacks Rank #1 (Strong Buy) value stocks list on December 16, 2024. |
zacks.com |
2024-12-16 11:46:21 |
Czytaj oryginał (ang.) |
| Zacks Industry Outlook Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems |
Becton, Dickinson, BD, McKesson, Cardinal Health and Merit Medical Systems have been highlighted in this Industry Outlook article. |
zacks.com |
2024-12-13 05:15:24 |
Czytaj oryginał (ang.) |
| Here's Why McKesson (MCK) is a Strong Value Stock |
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
zacks.com |
2024-12-12 12:41:25 |
Czytaj oryginał (ang.) |